维普期刊资源整合服务平台（V6.5）

88篇 您的检索式：作者名="van GAAL LF"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes : a randomized trial 显示文摘	Heine RJ Van Gaal LF Johns D	2005	Ann Intern Med2005，143，8：	1
2	Exenatide versus in- sulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trail显示文摘	Heine R J Van Gaal LF Johns D	2005	Ann Intern Med2005，143，8：	1
3	Mechanisms linking obesity with cardiovascular disease 显示文摘	Van Gaal LF Mertens IL De Block CE	2006	Nature2006，444，7121：	1
4	Mechanisms linking obesity with cardiovascular disease显示文摘	Van Gaal LF Mertens IL De Block CE	2006	Nature2006，444，7121：	1
5	Mechanisms linking obesity with cardiovascular disease显示文摘	Van Gaal LF Mertens IL De Block CE	2006	Nature2006，444，7121：	1
6	Mechanisms linking obesity with cardiovascular disease显示文摘	Van Gaal LF Mertens IL De Block CE	2006	Nature2006，444，7121：	1
7	Mechanisms linking obe- sity with cardiovascular disease 显示文摘	Van Gaal LF Mertens IL De Block CE	2006	Nature2006，444，7121：	1
8	Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients:1 -year experience from the RIO-Europe study显示文摘	VAN GAAL LF RISSANEN AM SCHEEN AJ	2005	Lancet2005，365，4：	1
9	Exenatide versus insulin glargine in patients with suboptimally controlled type 2diabetes: a randomized trial显示文摘	HEINE RJ van GAAL LF JOHNS D et oi	2005	Ann Intern Med2005，143，8：	1
10	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial 显示文摘	Heine RJ Van Gaal LF Johns D	2005	Ann Inter Med2005，143，8：	1
11	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial显示文摘	Heine RJ Van Gaal LF Johns D	2005	Ann Intern Med2005，143，：	1
12	Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients:1-year experience from the RIO-Europe study显示文摘	Pagotto U Pasquali R Van Gaal LF	2005	Lancet2005，365，9468：	1
13	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial显示文摘	Heine RJ Van Gaal LF Johns D	2005	Ann Intern Meal2005，143，8：	1
14	Continuous glucose monitoring in medical intensive careunit 显示文摘	de Block CEM M anuely Keenoy B van Gaal LF	2005	Continuous Glucose Monitoring2005，37，：	1
15	Effects of the cannabinoid-1 receptor blocker rimonabanton weight reduction and cardiovascular risk factos in overweight patients:1-year experience from the ROI-Europe study显示文摘	Van Gaal LF Rissanen AM Scheen AJ	2005	Lancet2005，365，9468：	1
16	Continuous glucose monitoring in medical in- tensive care unit 显示文摘	De Block CEM Keenoy MB van Gaal LF	2005	Continuous Glucose Monitoring2005，37，：	1
17	Human leptin: from an adipocyte hormone to an endocrine mediator显示文摘	WAUTERS M CONSIDINE RV VAN GAAL LF	2000	European Journal of Endocrinology2000，143，：	1
18	Effects of the cannabi-noid-1 receptor blocker rimonabant on weight reduction and cardio-vascular risk factors in overweight patients:1-year experience fromthe RIO-Europe study显示文摘	Van Gaal LF Rissanen AM Scheen AJ	2005	Lancet2005，365，9468：	1
19	Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovas-cular risk factors in overweight patients:1-year experience from the RIOEurupe study显示文摘	Van Gaal LF Rissanen AM Scheen A J Ziegler O Rossner S	2005	Lancet2005，365，9468：	1
20	Mechanisms linking obesity with eardio vascular disease 显示文摘	van Gaal LF Mertens IL de Block CE	2006	Nature2006，，444：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示